Balanced news tone
News Sentiment
OPRX sentiment intelligence
OPTIMIZERx Corp news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
83/100 classification confidence.
directly relevant articles
high-authority source matches
+3.6% over one week, +22.6% over four weeks, trend inactive, and below fair value.
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 11:30
- Source
- GlobeNewswire
OptimizeRx Stock Down 30% in a Month: Should Investors Hold or Fold?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 May 2026 07:00
- Source
- Market source
OptimizeRx Cuts Revenue Outlook: Will Pressures Ease Ahead?
- Tone
- Negative 42/100
- Event
- Earnings
- Published
- 15 May 2026 14:09
- Source
- Zacks
Need To Know: Analysts Just Made A Substantial Cut To Their OptimizeRx Corporation (NASDAQ:OPRX) Estimates
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
OptimizeRx Corporation (OPRX) Releases Q1 2026 Earnings: Revenue Down but Beats; EPS Miss
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 May 2026 07:00
- Source
- Quiver Quantitative
OptimizeRx Corp. (OPRX) Surpasses Q1 Earnings and Revenue Estimates
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 May 2026 07:00
- Source
- Market source
Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 05 May 2026 07:00
- Source
- Market source
OptimizeRx vs. GoodRx: Which Digital Health Stock is the Better Buy?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 24 Apr 2026 07:00
- Source
- Market source
How The OptimizeRx (OPRX) Narrative Is Shifting As Revenue Caution Meets Profit Optimism
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 18 Apr 2026 07:00
- Source
- Market source
Should Value Investors Buy OptimizeRx (OPRX) Stock?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 17 Apr 2026 07:00
- Source
- Market source
OptimizeRx (OPRX) Soars 5.9%: Is Further Upside Left in the Stock?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 26 Mar 2026 07:00
- Source
- Market source
Is OptimizeRx Stock Built to Withstand More Downside?
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 20 Dec 2025 08:00
- Source
- Trefis
Optimizerx
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Nov 2025 08:00
- Source
- Forbes
Optimizerx (OPRX) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Apr 2025 23:15
- Source
- Stock Titan
Optimizerx (OPRX) Stock News & Updates
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Sep 2020 05:26
- Source
- Stock Titan